Breast Cancer and Bone Metastasis

Yoneda, Toshiyuki

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 5R01CA063628-02
• Application #: 2105602
• Study Section: Orthopedics and Musculoskeletal Study Section (ORTH)
• Project Start: 1995-03-10
• Project End: 1999-12-31
• Budget Start: 1996-01-01
• Budget End: 1996-12-31
• Support Year: 2
• Fiscal Year: 1996

Institution

• Name: University of Texas Health Science Center San Antonio
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 800772162
• City: San Antonio
• State: TX
• Country: United States
• Zip Code: 78229

Publications

Zweemer, R P; Shaw, P A; Verheijen, R M et al. (1999) Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations. J Clin Pathol 52:372-5

Yoneda, T (1998) Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone. Eur J Cancer 34:240-5

Michigami, T; Nomizu, M; Yamada, Y et al. (1998) Growth and dissemination of a newly-established murine B-cell lymphoma cell line is inhibited by multimeric YIGSR peptide. Clin Exp Metastasis 16:645-54

Yoneda, T; Sasaki, A; Dunstan, C et al. (1997) Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. J Clin Invest 99:2509-17

Mbalaviele, G; Dunstan, C R; Sasaki, A et al. (1996) E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res 56:4063-70